507 related articles for article (PubMed ID: 17651013)
1. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
Tagami T; Hagiwara H; Kimura T; Usui T; Shimatsu A; Naruse M
Thyroid; 2007 Aug; 17(8):767-72. PubMed ID: 17651013
[TBL] [Abstract][Full Text] [Related]
2. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
Yoshihara A; Noh JY; Mukasa K; Suzuki M; Ohye H; Matsumoto M; Kunii Y; Watanabe N; Suzuki N; Kameda T; Sugino K; Ito K
Endocr J; 2015; 62(6):557-60. PubMed ID: 25819223
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
Izumi Y; Takeoka K; Amino N
Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
[TBL] [Abstract][Full Text] [Related]
4. Gestational and Postpartum Complications in Patients with First Trimester Thyrotoxicosis: A Prospective Multicenter Cohort Study from Northeast China.
Xu Y; Li C; Wang W; Yu X; Liu A; Shi Y; Xie X; Li J; Li Y; Shan Z; Teng W; Li Y
Thyroid; 2023 Jun; 33(6):762-770. PubMed ID: 37051708
[No Abstract] [Full Text] [Related]
5. [A clinical study on gestational transient thyrotoxicosis].
Wen BH; Teng WP; Shan ZY; Li YB; Li J; Gao B; Shang T; Zhou JR; Li CY; Zhou WW; Ding B; Ma Y; Wu Y; Liu Q; Liu W; Yu XH; Chen YY; Wang WW; Fan CL; Wang H; Guo R
Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):1003-7. PubMed ID: 19134305
[TBL] [Abstract][Full Text] [Related]
6. Pitfalls in the assessment of gestational transient thyrotoxicosis.
Iijima S
Gynecol Endocrinol; 2020 Aug; 36(8):662-667. PubMed ID: 32301638
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
Ide A; Amino N; Kang S; Yoshioka W; Kudo T; Nishihara E; Ito M; Nakamura H; Miyauchi A
Thyroid; 2014 Jun; 24(6):1027-31. PubMed ID: 24400892
[TBL] [Abstract][Full Text] [Related]
8. MANAGEMENT OF THYROTOXICOSIS: PRECONCEPTION, PREGNANCY, AND THE POSTPARTUM PERIOD.
Pearce EN
Endocr Pract; 2019 Jan; 25(1):62-68. PubMed ID: 30289300
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease.
Amino N; Yabu Y; Miyai K; Fujie T; Azukizawa M; Onishi T; Kumahara Y
Lancet; 1978 Aug; 2(8085):344-6. PubMed ID: 79711
[TBL] [Abstract][Full Text] [Related]
10. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy.
Rotondi M; Cappelli C; Pirali B; Pirola I; Magri F; Fonte R; Castellano M; Rosei EA; Chiovato L
J Clin Endocrinol Metab; 2008 Oct; 93(10):3985-8. PubMed ID: 18664537
[TBL] [Abstract][Full Text] [Related]
11. New-onset Graves' disease in the postpartum period.
Goldstein AL
J Midwifery Womens Health; 2013; 58(2):211-4. PubMed ID: 23590488
[TBL] [Abstract][Full Text] [Related]
12. Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease.
Zimmermann-Belsing T; Nygaard B; Rasmussen AK; Feldt-Rasmussen U
Eur J Endocrinol; 2002 Feb; 146(2):173-7. PubMed ID: 11834425
[TBL] [Abstract][Full Text] [Related]
13. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease.
Amino N; Tanizawa O; Mori H; Iwatani Y; Yamada T; Kurachi K; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1982 Jul; 55(1):108-12. PubMed ID: 6896207
[TBL] [Abstract][Full Text] [Related]
14. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
Yoshimura Noh J; Momotani N; Fukada S; Ito K; Miyauchi A; Amino N
Endocr J; 2005 Oct; 52(5):537-42. PubMed ID: 16284430
[TBL] [Abstract][Full Text] [Related]
15. Thyrotropin Receptor Antibody Levels at Diagnosis and After Thionamide Course Predict Graves' Disease Relapse.
Tun NN; Beckett G; Zammitt NN; Strachan MW; Seckl JR; Gibb FW
Thyroid; 2016 Aug; 26(8):1004-9. PubMed ID: 27266892
[TBL] [Abstract][Full Text] [Related]
16. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
[TBL] [Abstract][Full Text] [Related]
17. Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period.
Momotani N; Noh J; Ishikawa N; Ito K
J Clin Endocrinol Metab; 1994 Jul; 79(1):285-9. PubMed ID: 7913091
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients with Graves' disease.
Kubota S; Takata K; Arishima T; Ohye H; Nishihara E; Kudo T; Ito M; Fukata S; Amino N; Miyauchi A
Thyroid; 2008 Jan; 18(1):63-6. PubMed ID: 18302519
[TBL] [Abstract][Full Text] [Related]
20. Thyroid dysfunction following pregnancy and implications for breastfeeding.
Amino N; Arata N
Best Pract Res Clin Endocrinol Metab; 2020 Jul; 34(4):101438. PubMed ID: 32651061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
